2014-03-21 21:22:47 UTC

Gastroenterology Podcast March 2014: Telaprevir Twice Daily Is Noninferior to Telaprevir Every 8 Hours for Chronic Hepatitis C

A phase-3 study in the March issue of Gastroenterology examined the safety and efficacy of twice-daily telaprevir in treatment-naive patients with chronic hepatitis C virus (HCV) genotype 1 infection, including those with cirrhosis. Dr. Kuemmerle discusses the results with first author Dr. Maria Buti; Plus, a rundown of top stories from this month's issue of GI and Hepatology News.

 

 

Buti M, Agarwal K, Horsmans Y, et al. Telaprevir Twice Daily Is Noninferior to Telaprevir Every 8 Hours for Patients With Chronic Hepatitis C. Gastroenterology 2014; March; 146(3): 744-753
Abstract

 

 

Duration: 14.52m
Filetype: mp3
Bitrate: 96 KBPS
Frequency: 44100 HZ

More on Hepatitis C

Principles of Gastroenterology for the NP and PA

Aug. 11, 2017

Hear from the experts as they provide you with critical updates on treating and managing patients with a variety of GI disorders.

New WHO Report: More Work Needed to Diagnose, Treat Viral Hepatitis Worldwide

June 22, 2017

Just 20 percent of people with hepatitis C have been diagnosed, and only 7 percent have been treated.

Member Benefit Spotlight: GastroSlides

June 15, 2017

Free access to AGA's GastroSlides is now a member benefit.